Endothelial anthrax toxin receptor 2 plays a protective role in liver fibrosis
Frontiers in Cell and Developmental Biology · 23.01.2024 · 11
DOI: 10.3389/fcell.2023.1278968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 23.01.2024. Verfasst von Xiaojuan Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University H…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma is one of the leading cancers worldwide and is a potential consequence of fibrosis. Therefore, the identification of key cellular and molecular mechanisms involved in liver fibrosis is an important goal for the development of new strategies to control liver-related diseases. Here, single-cell RNA sequencing data (GSE136103 and GES181483) of clinical liver non-parenchymal cells were analyzed to identify cellular and molecular mechanisms of liver fibrosis. The proportion of endothelial subpopulations in cirrhotic livers was significantly higher than that in healthy livers. Gene ontology and gene set enrichment analysis of differentially expressed genes in the endothelial subgroups revealed that extracellular matrix (ECM)-related pathways were significantly enriched. Since anthrax toxin receptor 2 (ANTXR2) interacts with the ECM, the expression of ANTXR2 in the liver endothelium was analyzed. ANTXR2 expression in the liver endothelium of wild-type (WT) mice significantly decreased after a 4-time sequential injection of carbon tetrachloride (CCl 4 ) to induce liver fibrosis. Next, conditional knockout mice selectively lacking Antxr2 in endothelial cells were generated. After endothelial-specific Antxr2 knockout mice were subjected to the CCl 4 model, the degree of liver fibrosis in the knockout group was significantly more severe than that in the control group. In addition, ANTXR2 in human umbilical vein endothelial cells promoted matrix metalloproteinase 2 (MMP2) activation to degrade the ECM in vitro . Finally, endothelial-specific overexpression of Antxr2 alleviated the development of liver fibrosis following adeno-associated virus treatment. Collectively, these results suggested that endothelial ANTXR2 plays a protective role in liver fibrosis. This function of ANTXR2 may be achieved by promoting MMP2 activation to degrade the ECM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, X., Zhang, L., Luo, W., Zeng, Y., Li, X., Yang, N., Huang, W., & Ding, B. S. (2024). Endothelial anthrax toxin receptor 2 plays a protective role in liver fibrosis. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1278968
Vancouver
Huang X, Zhang L, Luo W, Zeng Y, Li X, Yang N, et al. Endothelial anthrax toxin receptor 2 plays a protective role in liver fibrosis. Frontiers in Cell and Developmental Biology. 2024;11. doi:10.3389/fcell.2023.1278968
BibTeX
@article{Huang2024,
author = {Huang, Xiaojuan and Zhang, Liyin and Luo, Wei and Zeng, Yu and Li, Xiaoxue and Yang, Nan and Huang, Wenwen and Ding, Bi-Sen},
title = {Endothelial anthrax toxin receptor 2 plays a protective role in liver fibrosis},
journal = {Frontiers in Cell and Developmental Biology},
year = {2024},
volume = {11},
doi = {10.3389/fcell.2023.1278968}
}
EUVIMED